Rubicon Organics Inc (ROMJ) - Net Assets

Latest as of March 2026: CA$41.64 Million CAD ≈ $30.12 Million USD

Based on the latest financial reports, Rubicon Organics Inc (ROMJ) has net assets worth CA$41.64 Million CAD (≈ $30.12 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$66.05 Million ≈ $47.78 Million USD) and total liabilities (CA$24.41 Million ≈ $17.66 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Rubicon Organics Inc (ROMJ) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets CA$41.64 Million
% of Total Assets 63.04%
Annual Growth Rate 15.48%
5-Year Change 13.26%
10-Year Change N/A
Growth Volatility 22.61

Rubicon Organics Inc - Net Assets Trend (2016–2025)

This chart illustrates how Rubicon Organics Inc's net assets have evolved over time, based on quarterly financial data. See Rubicon Organics Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Rubicon Organics Inc (2016–2025)

The table below shows the annual net assets of Rubicon Organics Inc from 2016 to 2025. For live valuation and market cap data, see Rubicon Organics Inc stock valuation.

Year Net Assets Change
2025-12-31 CA$44.06 Million
≈ $31.87 Million
+17.79%
2024-12-31 CA$37.40 Million
≈ $27.06 Million
-1.30%
2023-12-31 CA$37.89 Million
≈ $27.41 Million
-1.14%
2022-12-31 CA$38.33 Million
≈ $27.73 Million
-1.46%
2021-12-31 CA$38.90 Million
≈ $28.14 Million
+34.87%
2020-12-31 CA$28.84 Million
≈ $20.86 Million
+55.77%
2019-12-31 CA$18.52 Million
≈ $13.39 Million
-16.07%
2018-12-31 CA$22.06 Million
≈ $15.96 Million
+32.20%
2017-12-31 CA$16.69 Million
≈ $12.07 Million
+38.31%
2016-12-31 CA$12.07 Million
≈ $8.73 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Rubicon Organics Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 2767.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components CA$137.09 Million 311.17%
Total Equity CA$44.06 Million 100.00%

Rubicon Organics Inc Competitors by Market Cap

The table below lists competitors of Rubicon Organics Inc ranked by their market capitalization.

Company Market Cap
Xu Yuan Packaging Technology Co Ltd
TWO:8421
$22.02 Million
U10 SA
PA:ALU10
$22.03 Million
Global Masters Fund Ltd
AU:GFL
$22.04 Million
VERDE AGRITECH LTD -3918
F:T48
$22.04 Million
NamSys Inc
V:CTZ
$21.95 Million
Master Pack Group Bhd
KLSE:7029
$21.94 Million
Guardian Exploration Inc
V:GX
$21.94 Million
Plastofil -L
TA:PPIL
$21.93 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Rubicon Organics Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 37,402,161 to 44,057,000, a change of 6,654,839 (17.8%).
  • Net income of 1,051,000 contributed positively to equity growth.
  • New share issuances of 4,162,000 increased equity.
  • Other factors increased equity by 1,441,839.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CA$1.05 Million +2.39%
Share Issuances CA$4.16 Million +9.45%
Other Changes CA$1.44 Million +3.27%
Total Change CA$- 17.79%

Book Value vs Market Value Analysis

This analysis compares Rubicon Organics Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.69x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 0.99x to 0.69x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 CA$0.45 CA$0.45 x
2018-12-31 CA$0.60 CA$0.45 x
2019-12-31 CA$0.46 CA$0.45 x
2020-12-31 CA$0.58 CA$0.45 x
2021-12-31 CA$0.69 CA$0.45 x
2022-12-31 CA$0.68 CA$0.45 x
2023-12-31 CA$0.67 CA$0.45 x
2024-12-31 CA$0.66 CA$0.45 x
2025-12-31 CA$0.66 CA$0.45 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Rubicon Organics Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 2.39%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.77%
  • • Asset Turnover: 0.89x
  • • Equity Multiplier: 1.52x
  • Recent ROE (2.39%) is above the historical average (-39.58%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 -35.06% -661.55% 0.04x 1.31x CA$-7.52 Million
2018 -135.42% -1472.44% 0.07x 1.28x CA$-32.08 Million
2019 -77.09% -3143.71% 0.01x 2.15x CA$-16.13 Million
2020 -51.95% -159.61% 0.18x 1.77x CA$-17.87 Million
2021 -37.33% -64.22% 0.41x 1.41x CA$-18.41 Million
2022 -10.06% -10.86% 0.63x 1.46x CA$-7.69 Million
2023 -4.81% -4.55% 0.73x 1.45x CA$-5.61 Million
2024 -6.85% -5.26% 0.86x 1.51x CA$-6.30 Million
2025 2.39% 1.77% 0.89x 1.52x CA$-3.35 Million

Industry Comparison

This section compares Rubicon Organics Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $713,486,636
  • Average return on equity (ROE) among peers: -56.91%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Rubicon Organics Inc (ROMJ) CA$41.64 Million -35.06% 0.59x $22.00 Million
Aurora Cannabis Inc (ACB) $1.69 Million -10.52% 0.00x $171.89 Million
Amotiv Limited (AOV) $795.11 Million 0.54% 0.21x $576.83 Million
Aequus Pharmaceuticals Inc (AQS) $-6.45 Million 0.00% 0.00x $479.73K
Avicanna Inc (AVCN) $3.46 Million -426.03% 4.09x $12.28 Million
Avant Brands Inc (AVNT) $32.85 Million -68.65% 0.81x $6.98 Million
Bausch Health Companies Inc (BHC) $5.94 Billion 40.44% 5.31x $1.87 Billion
CanadaBis Capital Inc (CANB) $2.63 Million 23.10% 4.88x $1.53 Million
Cannabist Company Holdings Inc (CBST) $266.93 Million -39.33% 0.51x $12.41 Million
Cipher Pharmaceuticals Inc (CPH) $18.41 Million -56.20% 0.05x $297.74 Million
Cardiol Therapeutics Inc Class A (CRDL) $76.24 Million -32.43% 0.15x $118.76 Million

About Rubicon Organics Inc

V:ROMJ Canada Drug Manufacturers - Specialty & Generic
Market Cap
$22.00 Million
CA$30.41 Million CAD
Market Cap Rank
#24832 Global
#960 in Canada
Share Price
CA$0.45
Change (1 day)
+1.12%
52-Week Range
CA$0.41 - CA$0.68
All Time High
CA$4.31
About

Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally. The company offers cannabis products in dried flower, pre-rolls, concentrates, gummies, capsules, edibles, vapes, topicals, relief sticks, and oils. It sells its products under the Simply Bare Organic… Read more